Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
PaperCitations, authors & open-access status
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 262 citations, 2021 year and green oa status.
262
Citations
2021
Year
green
OA Status